Investigators compared bariatric surgery with a community weight management intervention in ability to reduce intracranial pressure among patients with idiopathic intracranial hypertension.
Intensive blood pressure treatment targeting systolic blood pressure <120 mm Hg results in lower rates of major adverse cardiovascular events and lower all-cause mortality than a standard treatment target among patients at increased cardiovascular risk.
HOPE-3 was designed to assess if reducing BP and/or LDL-C would reduce cardiovascular events in study participants at intermediate risk with no prior cardiovascular events.
Elevated systolic blood pressure, high serum total cholesterol, and obesity from childhood through adulthood are inversely associated with midlife cognitive performance.
Consideration should be given to the addition of medications for adults with stage 1 hypertension not meeting blood pressure goals after six months of lifestyle therapy.
